These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 19770055

  • 21. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease.
    Ishii K, Sasaki M, Kitagaki H, Yamaji S, Sakamoto S, Matsuda K, Mori E.
    J Nucl Med; 1997 Jun; 38(6):925-8. PubMed ID: 9189143
    [Abstract] [Full Text] [Related]

  • 22. Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18.
    Yakushev I, Landvogt C, Buchholz HG, Fellgiebel A, Hammers A, Scheurich A, Schmidtmann I, Gerhard A, Schreckenberger M, Bartenstein P.
    Psychiatry Res; 2008 Nov 30; 164(2):143-53. PubMed ID: 18930634
    [Abstract] [Full Text] [Related]

  • 23. Voxel-based classification of FDG PET in dementia using inter-scanner normalization.
    Thiele F, Young S, Buchert R, Wenzel F.
    Neuroimage; 2013 Aug 15; 77():62-9. PubMed ID: 23541799
    [Abstract] [Full Text] [Related]

  • 24. [Differences in cerebral glucose metabolism between frontotemporal lobar degeneration and Alzheimer's disease].
    Poljansky S, Ibach B, Vogel M, Männer P, Marienhagen J, Hajak G.
    Psychiatr Prax; 2004 Nov 15; 31 Suppl 1():S73-5. PubMed ID: 15570509
    [Abstract] [Full Text] [Related]

  • 25. Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.
    Castellano CA, Nugent S, Paquet N, Tremblay S, Bocti C, Lacombe G, Imbeault H, Turcotte É, Fulop T, Cunnane SC.
    J Alzheimers Dis; 2015 Nov 15; 43(4):1343-53. PubMed ID: 25147107
    [Abstract] [Full Text] [Related]

  • 26. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
    Albin RL, Koeppe RA, Burke JF, Giordani B, Kilbourn MR, Gilman S, Frey KA.
    Arch Neurol; 2010 Apr 15; 67(4):440-6. PubMed ID: 20385910
    [Abstract] [Full Text] [Related]

  • 27. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
    Cerami C, Della Rosa PA, Magnani G, Santangelo R, Marcone A, Cappa SF, Perani D.
    Neuroimage Clin; 2015 Apr 15; 7():187-94. PubMed ID: 25610780
    [Abstract] [Full Text] [Related]

  • 28. Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study.
    Diehl-Schmid J, Grimmer T, Drzezga A, Bornschein S, Riemenschneider M, Förstl H, Schwaiger M, Kurz A.
    Neurobiol Aging; 2007 Jan 15; 28(1):42-50. PubMed ID: 16448722
    [Abstract] [Full Text] [Related]

  • 29. Reference cluster normalization improves detection of frontotemporal lobar degeneration by means of FDG-PET.
    Dukart J, Perneczky R, Förster S, Barthel H, Diehl-Schmid J, Draganski B, Obrig H, Santarnecchi E, Drzezga A, Fellgiebel A, Frackowiak R, Kurz A, Müller K, Sabri O, Schroeter ML, Yakushev I.
    PLoS One; 2013 Jan 15; 8(2):e55415. PubMed ID: 23451025
    [Abstract] [Full Text] [Related]

  • 30. Positron emission tomography imaging in dementia.
    Herholz K, Carter SF, Jones M.
    Br J Radiol; 2007 Dec 15; 80 Spec No 2():S160-7. PubMed ID: 18445746
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases.
    Daerr S, Brendel M, Zach C, Mille E, Schilling D, Zacherl MJ, Bürger K, Danek A, Pogarell O, Schildan A, Patt M, Barthel H, Sabri O, Bartenstein P, Rominger A.
    Neuroimage Clin; 2017 Dec 15; 14():77-86. PubMed ID: 28138429
    [Abstract] [Full Text] [Related]

  • 32. Brain FDG PET and the diagnosis of dementia.
    Shivamurthy VK, Tahari AK, Marcus C, Subramaniam RM.
    AJR Am J Roentgenol; 2015 Jan 15; 204(1):W76-85. PubMed ID: 25539279
    [Abstract] [Full Text] [Related]

  • 33. Construction and comparative evaluation of different activity detection methods in brain FDG-PET.
    Buchholz HG, Wenzel F, Gartenschläger M, Thiele F, Young S, Reuss S, Schreckenberger M.
    Biomed Eng Online; 2015 Aug 18; 14():79. PubMed ID: 26281849
    [Abstract] [Full Text] [Related]

  • 34. Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP.
    Kono AK, Ishii K, Sofue K, Miyamoto N, Sakamoto S, Mori E.
    Eur J Nucl Med Mol Imaging; 2007 Sep 18; 34(9):1490-7. PubMed ID: 17318545
    [Abstract] [Full Text] [Related]

  • 35. Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease.
    Verclytte S, Lopes R, Lenfant P, Rollin A, Semah F, Leclerc X, Pasquier F, Delmaire C.
    J Neuroimaging; 2016 Sep 18; 26(2):207-12. PubMed ID: 26031943
    [Abstract] [Full Text] [Related]

  • 36. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, Kuhl DE, Schwaiger M.
    J Nucl Med; 2001 Apr 18; 42(4):548-57. PubMed ID: 11337540
    [Abstract] [Full Text] [Related]

  • 37. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB.
    Neuroimage; 2010 Aug 15; 52(2):488-96. PubMed ID: 20385246
    [Abstract] [Full Text] [Related]

  • 38. Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index.
    Döbert N, Pantel J, Frölich L, Hamscho N, Menzel C, Grünwald F.
    Dement Geriatr Cogn Disord; 2005 Aug 15; 20(2-3):63-70. PubMed ID: 15908747
    [Abstract] [Full Text] [Related]

  • 39. FDG PET imaging in patients with pathologically verified dementia.
    Hoffman JM, Welsh-Bohmer KA, Hanson M, Crain B, Hulette C, Earl N, Coleman RE.
    J Nucl Med; 2000 Nov 15; 41(11):1920-8. PubMed ID: 11079505
    [Abstract] [Full Text] [Related]

  • 40. Data-driven identification of intensity normalization region based on longitudinal coherency of 18F-FDG metabolism in the healthy brain.
    Zhang H, Wu P, Ziegler SI, Guan Y, Wang Y, Ge J, Schwaiger M, Huang SC, Zuo C, Förster S, Shi K.
    Neuroimage; 2017 Feb 01; 146():589-599. PubMed ID: 27693611
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.